The new integrase inhibitor dolutegravir worked better than boosted darunavir for people starting HIV treatment for the first time, researchers reported at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy last week in Denver.
http://www.hivandhepatitis.com/hiv-treatment/approved-hiv-drugs/4291-icaac-2013-dolutegravir-shows-good-efficacy-across-broad-range-of-patient-groups
http://www.hivandhepatitis.com/hiv-treatment/approved-hiv-drugs/4291-icaac-2013-dolutegravir-shows-good-efficacy-across-broad-range-of-patient-groups
No comments:
Post a Comment